Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Carcinoma, Ovarian Epithelial × liposomal doxorubicin × Clear all

Phase

Phase 1/2 6 Phase 3 5 Phase 2 5 Phase 1 5 Phase NA 1 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Wilms Tumor 1 Ovarian Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Carcinoma, Ovarian Epithelial 1

Interventions

niraparib 1 liposomal doxorubicin 1 fluciclovine F-18 1 Paclitaxel 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03794778 2022-07-18

Evaluation of PLD Combined With Carboplatin Versus Paclitaxel Plus Carboplatin in the First-line Treatment of Epithelial Ovarian Cancer

Women's Hospital School Of Medicine Zhejiang University

Phase 4 Unknown

Carcinoma, Ovarian Epithelial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡